Dr. Gerald Miele, MD

NPI: 1073555207
Total Payments
$153,543
2024 Payments
$32.27
Companies
11
Transactions
207

Payment Breakdown by Category

Other$118,283 (77.0%)
Travel$26,555 (17.3%)
Consulting$4,901 (3.2%)
Food & Beverage$3,509 (2.3%)
Education$295.41 (0.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $118,283 48 77.0%
Travel and Lodging $26,555 82 17.3%
Consulting Fee $4,901 1 3.2%
Food and Beverage $3,509 61 2.3%
Education $295.41 15 0.2%

Top Paying Companies

Company Total Records Latest Year
Novo Nordisk Inc $147,253 179 $0 (2024)
SANOFI-AVENTIS U.S. LLC $5,924 6 $0 (2018)
Amgen Inc. $136.60 4 $0 (2018)
Amarin Pharma Inc. $125.97 4 $0 (2020)
Merck Sharp & Dohme Corporation $26.42 2 $0 (2020)
Arbor Pharmaceuticals, Inc. $23.72 2 $0 (2017)
Daiichi Sankyo Inc. $14.15 1 $0 (2017)
Abbott Laboratories $12.26 1 $0 (2021)
Lilly USA, LLC $11.30 1 $0 (2017)
Valeant Pharmaceuticals North America LLC $10.86 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2024 $32.27 1 Novo Nordisk Inc ($32.27)
2021 $12.26 1 Abbott Laboratories ($12.26)
2020 $45.33 9 Merck Sharp & Dohme Corporation ($26.42)
2019 $35,023 45 Novo Nordisk Inc ($34,911)
2018 $70,723 80 Novo Nordisk Inc ($64,679)
2017 $47,707 71 Novo Nordisk Inc ($47,631)

All Payment Transactions

207 individual payment records from CMS Open Payments — Page 1 of 9

Date Company Product Nature Form Amount Type
04/17/2024 Novo Nordisk Inc Wegovy (Drug) Education In-kind items and services $32.27 General
Category: Obesity
11/18/2021 Abbott Laboratories FreeStyle Libre 2 (Device) Food and Beverage In-kind items and services $12.26 General
Category: Diabetes Care
12/10/2020 Travere Therapeutics, Inc. (820) Cholbam (Drug) Education In-kind items and services $0.83 General
Category: Hepatology
12/10/2020 Travere Therapeutics, Inc. (820) Cholbam (Drug) Education In-kind items and services $0.83 General
Category: Hepatology
11/05/2020 Amarin Pharma Inc. Vascepa (Drug) Food and Beverage In-kind items and services $13.93 General
Category: Cardiovascular
08/14/2020 Travere Therapeutics, Inc. (820) Cholbam (Drug) Education In-kind items and services $0.83 General
Category: Hepatology
08/14/2020 Travere Therapeutics, Inc. (820) Cholbam (Drug) Education In-kind items and services $0.83 General
Category: Hepatology
02/24/2020 Merck Sharp & Dohme Corporation JANUVIA (Drug), BELSOMRA, STEGLATRO Food and Beverage In-kind items and services $13.76 General
Category: ENDOCRINOLOGY
02/05/2020 Travere Therapeutics, Inc. (820) Cholbam (Drug) Education In-kind items and services $0.83 General
Category: Hepatology
02/05/2020 Travere Therapeutics, Inc. (820) Cholbam (Drug) Education In-kind items and services $0.83 General
Category: Hepatology
01/29/2020 Merck Sharp & Dohme Corporation JANUVIA (Drug), JANUMET, STEGLATRO Food and Beverage In-kind items and services $12.66 General
Category: ENDOCRINOLOGY
10/16/2019 Novo Nordisk Inc Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $688.50 General
09/17/2019 Amarin Pharma Inc. Vascepa (Drug) Food and Beverage In-kind items and services $1.35 General
Category: Hypertriglyceridemia
08/07/2019 Novo Nordisk Inc Tresiba (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,767.50 General
Category: Diabetes
08/07/2019 Novo Nordisk Inc Tresiba (Drug) Travel and Lodging In-kind items and services $421.08 General
Category: Diabetes
08/07/2019 Novo Nordisk Inc Tresiba (Drug) Travel and Lodging In-kind items and services $180.24 General
Category: Diabetes
08/07/2019 Novo Nordisk Inc Tresiba (Drug) Food and Beverage In-kind items and services $37.99 General
Category: Diabetes
06/28/2019 Novo Nordisk Inc Ozempic (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,767.50 General
Category: Diabetes
06/28/2019 Novo Nordisk Inc Ozempic (Drug) Travel and Lodging In-kind items and services $1,156.04 General
Category: Diabetes
06/28/2019 Novo Nordisk Inc Ozempic (Drug) Food and Beverage In-kind items and services $15.27 General
Category: Diabetes
06/13/2019 Novo Nordisk Inc Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $229.50 General
06/05/2019 Novo Nordisk Inc Tresiba (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,902.50 General
Category: Diabetes
06/05/2019 Novo Nordisk Inc Tresiba (Drug) Travel and Lodging In-kind items and services $444.28 General
Category: Diabetes
06/05/2019 Novo Nordisk Inc Tresiba (Drug) Travel and Lodging In-kind items and services $141.99 General
Category: Diabetes
06/05/2019 Novo Nordisk Inc Tresiba (Drug) Food and Beverage In-kind items and services $9.78 General
Category: Diabetes

About Dr. Gerald Miele, MD

Dr. Gerald Miele, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Florence, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1073555207.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gerald Miele, MD has received a total of $153,543 in payments from pharmaceutical and medical device companies, with $32.27 received in 2024. These payments were reported across 207 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($118,283).

Practice Information

  • Specialty Endocrinology, Diabetes & Metabolism
  • Other Specialties Diabetes & Metabolism
  • Location Florence, SC
  • Active Since 06/12/2006
  • Last Updated 10/17/2007
  • Taxonomy Code 207RE0101X
  • Entity Type Individual
  • NPI Number 1073555207

Products in Payments

  • Tresiba (Drug) $77,707
  • Victoza (Drug) $29,084
  • Ozempic (Drug) $19,505
  • Xultophy 100/3.6 (Drug) $8,854
  • SOTAGLIFLOZIN (Drug) $5,924
  • Xultophy (Drug) $220.00
  • Vascepa (Drug) $125.97
  • Repatha (Biological) $107.74
  • Wegovy (Drug) $32.27
  • JANUVIA (Drug) $26.42
  • Edarbi (Drug) $23.72
  • Prolia (Biological) $16.60
  • Movantik (Drug) $14.15
  • Aimovig (Biological) $12.26
  • FreeStyle Libre 2 (Device) $12.26
  • FORTEO (Drug) $11.30
  • XIFAXAN (Drug) $10.86
  • (820) Cholbam (Drug) $4.98

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Endocrinology, Diabetes & Metabolism Doctors in Florence